The Hemophilia B Gene Therapy market size is expected to reach $2.01 billion in 2030 at a CAGR of 29.8%, driven by expanding gene therapy trials.
Read More
The Gynecomastia Treatment market size is expected to reach $4.49 billion in 2030 at a CAGR of 8.6%, driven by rising male aesthetic procedure demand.
Read More
The Gynecological Dilators market size is expected to reach $2.36 billion in 2030 at a CAGR of 6.3%, driven by minimally invasive surgical adoption.
Read More
The Group B Streptococcus Infection Treatment market size is expected to reach $1.89 billion in 2030 at a CAGR of 8.6%, driven by rising healthcare expenditure.
Read More
The Good Manufacturing Practice (GMP) Services For Cell And Gene Therapy market size is expected to reach $5.88 billion in 2030 at a CAGR of 18.9%, driven by rising cell and gene therapy trials.
Read More
The Giant Papillary Conjunctivitis market size is expected to reach $1.06 billion in 2030 at a CAGR of 8.0%, driven by increasing use of contact lenses.
Read More
The Gene Therapy Bioassays market size is expected to reach $2.62 billion in 2030 at a CAGR of 16.7%, driven by rising gene therapy clinical trials.
Read More
The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market size is expected to reach $2.42 billion in 2030 at a CAGR of 32.9%, driven by rising myeloma prevalence.
Read More
The Frontotemporal Dementia market size is expected to reach $4.99 billion in 2030 at a CAGR of 9.0%, driven by growing adoption of precision medicine.
Read MoreThe Frontotemporal Dementia market size is expected to reach $4.99 billion in 2030 at a CAGR of 9.0%, driven by growing adoption of precision medicine.
Read More